Pharmacodynamic endpoints in primary breast cancer.
Di Cosimo
S
S
Vall d'Hebron University Hospital, Barcelona, Spain.
Baselga
J
J
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor